Choate Investment Advisors Biogen Inc. Transaction History

Choate Investment Advisors

$3.79 Billion
Q2 2024

A detailed history of Choate Investment Advisors transactions in Biogen Inc. stock. As of the latest transaction made, Choate Investment Advisors holds 1,542 shares of BIIB stock, worth $286,318. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,542

Previous 1,580 2.41%

Holding current value

$286,318

Previous $340,000 5.0%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $7,239 - $8,995	-38 Reduced 2.41%	1,542 $357,000
Q1 2024 May 07, 2024	SELL	$212.02 - $267.71 $17,597 - $22,219	-83 Reduced 4.99%	1,580 $340,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $13,355 - $16,076	-60 Reduced 3.48%	1,663 $430,000
Q3 2023 Oct 30, 2023	BUY	$253.3 - $285.89 $107,905 - $121,789	426 Added 32.85%	1,723 $442,000
Q2 2023 Aug 01, 2023	BUY	$275.25 - $318.06 $45,141 - $52,161	164 Added 14.47%	1,297 $369,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $5,806 - $7,054	23 Added 2.07%	1,133 $313,000
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $11,627 - $13,827	-62 Reduced 5.29%	1,110 $226,000
Q1 2022 Apr 29, 2022	SELL	$193.77 - $244.14 $2,712 - $3,417	-14 Reduced 1.18%	1,172 $247,000
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $116,438 - $149,640	-520 Reduced 30.48%	1,186 $285,000
Q3 2021 Nov 04, 2021	BUY	$282.99 - $369.05 $36,788 - $47,976	130 Added 8.25%	1,706 $482,000
Q2 2021 Jul 30, 2021	BUY	$259.0 - $414.71 $108,780 - $174,178	420 Added 36.33%	1,576 $546,000
Q1 2021 May 07, 2021	BUY	$242.95 - $284.63 $33,527 - $39,278	138 Added 13.56%	1,156 $323,000
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $35,479 - $40,965	-134 Reduced 11.63%	1,018 $288,000
Q2 2020 Jul 23, 2020	SELL	$258.66 - $342.55 $2,586 - $3,425	-10 Reduced 0.86%	1,152 $308,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $19,894 - $25,236	-74 Reduced 5.99%	1,162 $368,000
Q4 2019 Jan 28, 2020	SELL	$220.06 - $304.07 $121,913 - $168,454	-554 Reduced 30.95%	1,236 $367,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $28,267 - $31,704	-130 Reduced 6.77%	1,790 $417,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $33,112 - $36,499	151 Added 8.54%	1,920 $449,000
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $23,187 - $36,268	-107 Reduced 5.7%	1,769 $418,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $30,913 - $39,155	-111 Reduced 5.59%	1,876 $565,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $29,351 - $38,383	100 Added 5.3%	1,987 $702,000
Q2 2018 Jul 30, 2018	SELL	$257.52 - $306.91 $38,370 - $45,729	-149 Reduced 7.32%	1,887 $548,000
Q1 2018 May 04, 2018	SELL	$260.13 - $367.91 $22,891 - $32,376	-88 Reduced 4.14%	2,036 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $597,162 - $700,261	2,124	2,124 $0

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Account

Choate Investment Advisors Biogen Inc. Transaction History